601567 三星医疗
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)10.14419.57418.56310.3187.889
总资产报酬率 ROA (%)5.1549.82610.0886.0994.832
投入资产回报率 ROIC (%)6.98012.94813.4018.1346.134

边际利润分析
销售毛利率 (%)28.97234.72433.91528.88225.368
营业利润率 (%)17.33317.70619.80812.66612.121
息税前利润/营业总收入 (%)16.13819.39119.65712.49913.315
净利润/营业总收入 (%)15.23915.57016.75710.60710.076

收益指标分析
经营活动净收益/利润总额(%)83.79688.62675.13191.41159.367
价值变动净收益/利润总额(%)10.3272.11118.263-1.95636.375
营业外收支净额/利润总额(%)1.3843.271-0.371-0.026-0.521

偿债能力分析
流动比率 (X)1.3311.7671.7851.4451.633
速动比率 (X)0.8761.2451.3091.1291.395
资产负债率 (%)46.61549.85448.15640.70739.866
带息债务/全部投入资本 (%)20.74327.73926.95213.81418.714
股东权益/带息债务 (%)348.065236.830247.302578.259415.457
股东权益/负债合计 (%)112.24899.010106.234143.897149.727
利息保障倍数 (X)-11.22017.848-254.951-76.56610.590

营运能力分析
应收账款周转天数 (天)75.76765.08567.65580.78097.126
存货周转天数 (天)130.674138.509120.21082.12761.477